Home
User Profile
  • 2011 Ph.D. Immunology/Veterinary Science, Department of Microbiology and Pathology, Washington State University, Pullman, WA Dissertation: “Immunogenicity and Linked Recognition of Anaplasma marginale Type IV Secretion System Proteins”.  
  • 2011 M.S. certificate in Protein Biotechnology, Department of Molecular Biosciences, Washington State University, Pullman, WA
  • 2011 M.B.A. certificate in Biotechnology Management, Department of Business Administration, Washington State University, Pullman, WA
  • 2012-present Research Fellow, Laser adjuvants for vaccines, Massachusetts General Hospital, Boston
  • Laser adjuvant as compared to other adjuvants
  • Laser adjuvant for Cholera vaccine
  • Molecular mechanisms of laser adjuvant
I have trained 4 students at VIC each having their own project. These people include:
  • Yusuke Shimaoka, MD candidate
  • Shu Takeuchi, MD candidate
  • Conor Dwyer, BA candidate
  • Megan Chan, BA candidate

Morse K, Norimine J, Hope JC, and Brown WC. Breadth of the CD4(+) T cell response to Anaplasma marginale VirB9-1, VirB9-2, and VirB10 and MHC class II DR and DQ restriction elements. Immunogenetics. 2012; 64(7): 507-523.
http://www.ncbi.nlm.nih.gov/pubmed/22361828

Morse K, Norimine J, Palmer GH, Sutten EL, Baszler TV, and Brown WC. Association and evidence for linked recognition of type IV secretion system VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale. Infection and Immunity. 2012; 80 (1): 215-227.
http://www.ncbi.nlm.nih.gov/pubmed/22038917

Sutten EL, Norimine J, Beare PA, Heinzen RA, Lopez JE, Morse K, Brayton KA, Gillespie JJ, and Brown WC. Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine. Infection and Immunity 2010; 78: 1314-1325.
http://www.ncbi.nlm.nih.gov/pubmed/20065028